表紙
市場調查報告書

感染疾病分子試驗市場 (敗血症,呼吸疾病,HIV,肝炎,結核 (TB) 試驗,STI,其他試驗)

Molecular Testing Markets for Infectious Diseases (Sepsis, Respiratory Diseases, HIV, Hepatitis, TB Testing, STIs and Other Tests)

出版商 Kalorama Information 商品編碼 911616
出版日期 內容資訊 英文 103 Pages
商品交期: 最快1-2個工作天內
價格
感染疾病分子試驗市場 (敗血症,呼吸疾病,HIV,肝炎,結核 (TB) 試驗,STI,其他試驗) Molecular Testing Markets for Infectious Diseases (Sepsis, Respiratory Diseases, HIV, Hepatitis, TB Testing, STIs and Other Tests)
出版日期: 2019年07月18日內容資訊: 英文 103 Pages
簡介

該報告評估了全球傳染病分子檢測市場中的市場機會和主要公司,並提供了市場趨勢,詳細的市場規模以及細分市場的預測。

第1章 摘要整理

第2章 感染疾病分子試驗市場上發展

  • 分子POC:新興競爭企業
  • 感染疾病診斷分子POC試驗的展望
  • STDS的存在感擴大
  • 新的真菌感染疾病著重質譜分析·定序
  • 美國感染疾病學會 (INFECTIOUS DISEASES SOCIETY OF 由於AMERICA) 的流感指南更新
  • 正在研究中的基於PCR的血液培養前菌血症診斷分析
  • Meridian收購GenePOC
  • T2Bacteria 研究顯示了最新研究等的價值、其他

第3章 感染疾病分子試驗市場

  • 全球市場分析
  • CT/NG,HPV及女性的健康
  • 肝炎
  • HIV
  • HAI (醫療相關感染)
  • 呼吸疾病
  • 分枝桿菌/結核

第4章 企業簡介

  • ABBOTT DIAGNOSTICS
  • BECTON, DICKINSON & CO. (BD)
  • BIO-RAD LABORATORIES
  • DANAHER (CEPHEID AND LEICA BIOSYSTEMS)
  • MERIDIAN BIOSCIENCE INC
  • QIAGEN N.V.
  • QUIDEL CORPORATION
  • ROCHE DIAGNOSTICS
目錄
Product Code: 19-046

Over half of the revenues earned in molecular diagnostics are earned by companies marketing tests to detect infectious disease. This Kalorama Information report examines the market opportunity for those tests, the companies that sell them, trends in the market and details segment-level market sizing and forecasts.

Test Segments: Market Sizing and Forecasts

There are several segments where testing at the molecular level has thrived, including the following:

  • HPV Testing
  • CT/NG Testing
  • Molecular Hepatitis Testing
  • HIV Testing
  • Hospital Acquired Infections and Sepsis Testing
  • Respiratory Diseases Testing
  • Mycobacteria/Tuberculosis Testing

The report does not contain information on blood banking, blood typing or NAT screen tests. These are covered in Kalorama Information's ‘The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 11th Edition’.

Regional Distribution

For each of these segments, the report provides a breakout for the following regions:

  • North America
  • Europe
  • Asia Pacific
  • Other

Company Profiles

Companies covered in this report include:

  • Abbott
  • bioMérieux
  • Bio-Rad
  • Cepheid
  • Meridian
  • Qiagen
  • Quidel
  • Roche

TABLE OF CONTENTS

CHAPTER ONE: EXECUTIVE SUMMARY

  • THE GLOBAL INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET
    • Figure 1-1 Molecular Infectious Disease Market, 2019-2014
  • TEST SEGMENTS
  • EMERGING TRENDS INFLUENCING THE MARKET LANDSCAPE

CHAPTER TWO: DEVELOPMENTS IN MOLECULAR INFECTIOUS DISEASE TESTING

  • MOLECULAR POC: UPSTART COMPETITORS
  • PROSPECTS FOR MOLECULAR POC TESTING FOR INFECTIOUS DISEASES DIAGNOSTICS
    • Table 2-1: Selected Molecular POC Platforms in the Market for Infectious Disease Testing
  • INCREASED PRESENCE OF STDS
  • LYME DISEASE: MAJOR IVD LEAPS IN WITH MOLECULAR SOLUTIONS
  • NEW FUNGAL INFECTION SPOTLIGHTS MASS SPEC AND SEQUENCING
  • UPDATED INFLUENZA GUIDELINES FROM THE INFECTIOUS DISEASES SOCIETY OF AMERICA
  • PCR-BASED ASSAY FOR DIAGNOSIS OF BACTEREMIA BEATS BLOOD CULTURES IN STUDY
  • MERIDIAN ACQUIRES GENEPOC
  • T2BACTERIA STUDY DEMONSTRATES WORTH IN RECENT STUDY
  • BRUKER COMPLETES ACQUISITION OF MAJORITY INTEREST IN INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS COMPANY HAIN LIFESCIENCE GMBH
  • REIMBURSEMENT ENVIRONMENT FOR MOLECULAR DIAGNOSTICS
  • NEW PROJECT USES SEQUENCING FOR TB DIAGNOSIS IN EMERGING NATIONS
  • GROWING MICROHOSPITAL BUSINESS BECKONS CLINICAL LABS
  • NEW EIGHT BACTERIA GRAM-NEGATIVE TEST CLEARED BY FDA
  • CLINICAL UTILITY OF MOLECULAR DIAGNOSTICS
  • AI ASSISTING WITH MOLECULAR COLORECTAL DIAGNOSIS

CHAPTER THREE: MARKETS FOR MOLECULAR INFECTIOUS DISEASE DIAGNOSTICS

  • Table 3-1: Selected Integrated Clinical Molecular Systems in the Market for Infectious Disease Diagnostics
  • MARKET ANALYSIS - GLOBAL
    • Table 3-2: Market by Segments (%) (HIV and Hepatitis, Hospital, STIs and HPV, Other)
    • Table 3-3: Global Molecular Infectious Disease Diagnostics Markets (2019-2024), by Infection ($, Million) (Hepatitis, HIV, HAIs/Sepsis, HPV, CT/NG, Respiratory Diseases, Mycobacteria/TB, Other, Total)
    • Table 3-4: Global Molecular Infectious Disease Diagnostics Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
  • CT/NG, HPV and Women's Health
    • Table 3-5: Global Molecular HPV Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
    • Table 3-6: Global Molecular CT/NG Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
  • Hepatitis
    • Table 3-7: Global Molecular Hepatitis Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
  • HIV
    • Table 3-8: Innovations in Molecular POC Diagnostics for HIV
    • Table 3-9: Global Molecular HIV Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
  • Hospital-Acquired Infections (HAIs)
    • Table 3-10: Global Molecular HAIs/Sepsis Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
  • Respiratory Diseases
    • Table 3-11: Global Molecular Respiratory Diseases Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
  • Mycobacteria/Tuberculosis
    • Table 3-12: Global Molecular Mycobacteria/TB Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)

CHAPTER FOUR: COMPANY PROFILES

  • ABBOTT DIAGNOSTICS
  • The Molecular Diagnostics Business Post-Acquisition of Alere
  • BECTON, DICKINSON & CO. (BD)
  • Business Segments
  • Molecular Diagnostics Focus
  • BIOM
  • Molecular
  • BIO-RAD LABORATORIES
  • DANAHER (CEPHEID AND LEICA BIOSYSTEMS)
  • Life Sciences Business
  • Diagnostics Business
  • Cepheid
  • Leica Biosystems
  • Danaher's 2018 Performance and 2019 Expectations
  • Acquisitions and Divestments in 2018 / 2019
  • MERIDIAN BIOSCIENCE INC
  • QIAGEN N.V.
  • Consumables and Related Revenues
  • Automation Platform and Instrumentation
  • Molecular Diagnostics Applications
  • Applied Testing
  • Pharma and Academia
  • New Developments (in 2018 until mid-2019)
  • Developments in Automation Systems
  • Bioinformatics Solutions
  • QUIDEL CORPORATION
  • ROCHE DIAGNOSTICS
  • Global Access Program for HIV
  • Core Molecular
  • cobas Liat System - POC
  • Partnering with Information Technology
  • Product Launches in 2018